SUPPLIERS GUIDE Point-of-care testing
THE BIOMEDICAL SCIENTIST
POINT-OF-CARE TESTING Point-of-care testing has been one of the big stories of diagnostics recently. Here, we look at the latest developments.
number of research and market analysts have published reports on the projected growth of the point-of-care testing (POCT) sector over the next ﬁve years. Grand View Research said the global POCT market was valued at $18.09bn in 2018 and expects it to rise to $22.8bn by 2025. Its report states: “Continuous developments in research and development activities to miniaturise molecular and professional
P01-42 IBMS Suppliers Guide 2020_All Pages_v11gh.indd 15
diagnostic tests is anticipated to drive the demand for the devices. “In addition, improvements in lab automation techniques coupled with introduction of cost-effective and high-quality medical solutions is set to propel the growth.” Other analysts are even more optimistic about growth. For example, Global Market Insights expects the sector value to hit $36.6bn by 2025. It predicts a that the most growth will be in microﬂuids technology (9.2%), followed by